BOSTON-3: An Open Label Follow-Up Study to Evaluate the Long Term Safety and Efficacy of L-CsA in Patients with a Diagnosis of CLAD-BOS after they have completed the participation to BOSTON 1 and BOSTON 2 studies
The objective of the trial is to assess the long-term safety and
efficacy of L-CsA plus Standard of Care (SoC) in the treatment of
BOS in single (SLT) and double lung transplant (DLT) recipients.
Study details
Study-ID: 2019-002987-29
Study-ID: 2019-002987-29
DZL Disease Area: ROR, DPLD, COPD
DZL Disease Area: ROR, DPLD, COPD
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: CPC-M
DZL Participating Sites: CPC-M
Start Date: 12.11.2020
Completion Date: 31.12.2026
Status: Closed
Status: Closed
DZL recruiting center
Disease: Patienten mit Einzel- oder Doppellungentransplantation
Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu.
Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.
